" class="no-js "lang="en-US"> BICO - Medtech Alert
Thursday, March 30, 2023
BICO | Pharmtech Focus


About BICO


We are industry-leading experts in Bio Convergence. By combining the power of biology, engineering and computer science, we create the future of health. We extend the boundaries of what’s possible to give people better and healthier lives.

Products from the BICO Group are trusted by more than 2,00 laboratories, including ones at all the top 20 pharmaceutical companies, are being used in more than 60 countries, and have been cited in more than 1800 publications. BICO is creating the future of health. Visit bico.com to learn more. BICO is listed on the Nasdaq Stockholm Main Market under BICO.

Related Story

BICO Group Adds Senior Ir Manager to Its Executive Management

May 12 2022

Åsa Hillsten has been appointed SVP and Head of IR at BICO and will be […]

BICO Acquires Allegro 3D, Adding New Light-based 3D Bioprinting Technology – Complementing the Existing Offering of Application Tailored Products

May 6 2022

BICO has acquired all the shares in San Diego-based Allegro 3D Inc. (“Allegro 3D”) for […]

CELLINK Launches the BIO CELLX, a First of its Kind Biodispensing Platform to Automate 3D Cell Culture

March 1 2022

Today CELLINK, A BICO Company, launched the BIO CELLX a novel system that automates 3D […]

Biosero Expands Laboratory Automation Capabilities with New Product Launches

February 23 2022

Biosero, Inc., a BICO company, and a developer of laboratory automation solutions to orchestrate scientific […]

BICO Partners with the Center for Contemporary Sciences (CCS) to Reduce Animal Testing in Life Sciences

January 14 2022

Today BICO, a leading bio convergence company, announced a partnership with the Center for Contemporary […]

CELLINK and Nanoscribe Join Forces to Launch the Quantum X Bio, the World’s Most Accurate 3D Bioprinter

December 16 2021

Today, BICO companies CELLINK and Nanoscribe announced the launch of the Quantum X bio, a revolutionary printing platform providing […]

BICO and Nanochon Announce Commercial Agreement to Develop 3D Printed Joint Restoration Implant

December 9 2021

Today BICO, the world’s leading bio convergence company, announced partnership with Nanochon, a startup developing regenerative joint replacements. Under […]

BICO’s CYTENA Signs USD 10 Million Deal to Distribute Single Cell Isolators in China to Accelerate Development of Next Generation Therapies

December 8 2021

Today CYTENA, a BICO company, announced it has signed a 2-year deal with Applitech Pharmaceutical Equipment Technology to […]

BICO Announces Appointment of Susan Tousi as New Member of the Board of Directors

November 18 2021

Today BICO, the world’s leading Bio Convergence company announced it has added Susan Tousi to […]

SCIENION & Cellenion Launch spheroONE ®, a Large-Particle Sorter and Dispenser to Advance Drug Testing on Complex In-Vitro 3D Models

October 27 2021

Today, SCIENION & Cellenion, BICO companies, announced the launch of spheroONE, an innovative single large-particle sorter and dispenser which will […]

BICO Strengthens IP Portfolio with Patents in the United States and Sweden for 3D Bioprinting of Temperature Sensitive Bioinks

October 14 2021

BICO, the world’s leading bio convergence company, has been granted two patents relating to the […]

Bico has Acquired Advanced Biomatrix, an Innovative Company Focused on 3d Applications, to, Together, Ensure a Market Leading Portfolio of Bioinks and Reagents

August 27 2021

BICO, the leading Bio Convergence company, has acquired all outstanding shares in Advanced BioMatrix Corp. […]